跳至主要内容
临床试验/EUCTR2018-001008-13-GR
EUCTR2018-001008-13-GR进行中(未招募)1 期

A SUPAR GUIDED DOUBLE BLIND RANDOMIZED CLINICAL TRIAL OF INITIATION OF ANTIBIOTICS FOR PRESUMED INFECTION AT THE EMERGENCY DEPARTMENT: THE SUPERIOR TRIAL - SUPERIOR

HELLENIC INSTITUTE FOR THE STUDY OF SEPSIS0 个研究点目标入组 220 人开始时间: 2018年5月15日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Written informed consent provided by the patient or by their legal representative in case of patients unable to consent
  • Age equal to or above 18 years
  • Male or female gender
  • Clinical suspicion of infection
  • qSOFA equal to 1 point
  • suPAR blood level equal or above 12 ng/ml
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 110
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 110

排除标准

  • Denial to consent
  • Patients with 2 or 3 qSOFA signs
  • Pregnancy (confirmed by blood or urinary pregnancy test) for female patients of reproductive age
  • Organ transplantation
  • Fully-blown sepsis with overt failing organs necessitating immediate resuscitation as defined by the attending physicians
  • Do not resuscitate decision

研究者

相似试验

招募中
4 期
STUDY OF COMPARING CHANGES IN VITALS AND INTRAOCULAR PRESSURE OF ETOMIDATE AND MIDAZOLAM IN PATIENTS OF HYPERTENSION AND CORONARY ARTERY DISEASE UNDERGOING CATARACT SURGERY DURING CONSCIOUS SEDATIO
CTRI/2016/11/007429SIR TAKHTSINHJI HOSPITA60
尚未招募
2 期
Effect of Gandha Taila Nasya (medicine administered through nasal route) in the management of Vishwachi (cervical spondylosis) and comparing its effect with Tila Taila Nasya (medicine administered through nasal route)
CTRI/2023/10/059210Dr MAMATHA
进行中(未招募)
1 期
CLINICAL TRIAL COMPARING PHARMACODYNAMIC, PHARMACOKINETIC AND SAFETY OFA BIOSIMILAR EPTACOG ALFA (ARYOSEVEN) AND NOVOSEVEN®, INPATIENTS WITH HAEMOPHILIA A OR B WITH INHIBITORSHAEMOPHILIA A OR B WITH INHIBITORSMedDRA version: 20.0Level: LLTClassification code 10053752Term: Hemophilia B with anti factor IXSystem Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10053751Term: Hemophilia A with anti factor VIIISystem Organ Class: 100000004850
EUCTR2019-002854-22-BGAryogen Pharmed48
已完成
不适用
A Clinical Trial of Levocarnitine to Treat Autism Spectrum DisordersAutism Spectrum Disorder (ASD)Mental and Behavioural DisordersPervasive developmental disorders
ISRCTN54273114Autism Research Institute (USA)30
终止
4 期
A clnical trIal comparing the effect of treatment with oral spironolactone compared with a placebo on the frequency and duration of atrIal fibrillation in patients with an implanted cardiac device in New Zealand.Atrial Fibrillation
ACTRN12616001188426niversity of Otago150